Abstract
Introduction
Although uncommon, there is significant morbidity and mortality associated with paediatric spinal glioblastoma. The paucity of cases makes treatment options difficult. The current recommended standard of care is biopsy followed by adjuvant chemo-radiotherapy, with emerging data supporting the role of safe gross total resection.
Objective
The purpose of this paper is to provide a single-institution case study and to discuss current and future therapeutic treatment strategies.
Case presentation
A 14-year-old boy presented with a 2-year history of intermittent back pain with recent progressively worsening motor and sensory deficits of the right side. Pre-operative MRI revealed an enhancing intra-medullary tumour extending from C2 to C7. During the operative case, no tumour–cord margin could be identified, and the patient underwent a subtotal excision. Histopathology confirmed glioblastoma. In the subsequent weeks, the patient's clinical condition deteriorated. Adjuvant therapy was declined by the family, and the patient died 9 weeks after initial presentation.
Conclusion
Despite major advances in surgical techniques, peri-operative neuro-imaging as well as chemo-radiotherapy, the prognosis of a paediatric intra-medullary high-grade spinal tumour remains poor. Detailed analysis of our understanding of tumour dynamics in this patient group is important in establishing future therapeutic strategies.
Similar content being viewed by others
References
Allen JC, Aviner S, Yates AJ, Boyett JM, Cherlow JM, Turski PA, Epstein F, Finlay JL (1998) Treatment of high-grade spinal cord astrocytoma of childhood with “8-in-1” chemotherapy and radiotherapy: a pilot study of CCG-945. Children's Cancer Group. J Neurosurg 88:215–220
Brat DJ, Shehata BM, Castellano-Sanchez AA, Hawkins C, Yost RB, Greco C, Mazewski C, Janss A, Ohgaki H, Perry A (2007) Congenital glioblastoma: a clinicopathologic and genetic analysis. Brain Pathol 17(3):276–281
Berhouma M, Bahri K, Houissa S, Zemmel I, Khouja N, Aouidj L, Jemel H, Khaldi M (2009) Managment of intramedullary spinal cord tumors: surgical considerations and results in 45 cases. Neurochirurgie 55:293–302
Cheng Y, Ng HK, Zhang SF, Ding M, Pang JC, Zheng J, Poon WS (1999) Genetic alterations in pediatric high-grade astrocytomas. Hum Pathol 30:1284–1290
Choi GH, Oh JK, Kim TY, You NK, Lee HS, Yoon do H, Ha Y, Yi S, Kim DS, Choi JU, Kim KN (2012) The clinical features and surgical outcomes of pediatric patients with primary spinal cord tumor. Childs Nerv Syst 28(6):897–904
Ciappetta P, Salvati M, Capoccia G (1991) Spinal glioblastomas: report of seven cases and review of the literature. Neurosurgery 28:302–306
Cohen AR, Wisoff JH, Allen JC, Epstein F (1989) Malignant astrocytomas of the spinal cord. J Neurosurg 70:50–54
Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, Brat DJ, Rosenblum MK, Hamilton RL, Lavey RS, Heideman RL (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol 13:317–323
Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ (2000) Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg 93:183–193
Crawford JR, Zaninovic A, Santi M, Rushing EJ, Olsen CH, Keating RF, Vezina G, Kadom N, Packer RJ (2009) Primary spinal cord tumors of childhood: effects of clinical presentation, radiographic features, and pathology on survival. J Neurooncol 95:259–269
Dunkel IJ, Garvin JH Jr, Goldman S, Ettinger LJ, Kaplan AM, Cairo M, Li H, Boyett JM, Finlay JL (1998) High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. J Neurooncol 37(1):67–73
Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, Turski PA, Wara WM, Edwards M, Sutton LN, Berger MS, Epstein F, Ayers G, Allen JC, Packer RJ (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight- drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 13(1):112–123
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27(28):4733–4740
Geyer JR, Finlay JL, Boyett JM, Wisoff JH, Yates A, Mao L, Packer RJ (1995) Survival of infants with malignant astrocytomas. A report from the Children's Cancer Group. Cancer 75(4):1045–1050
Gururangan S, Chi SN, Young Poussaint T, Onar-Thomas A, Gilbertson RJ, Vajapeyam S, Friedman HS, Packer RJ, Rood BN, Boyett JM, Kun LE (2010) Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. J Clin Oncol 28(18):3069–3075
Iwata K, Nakagawa H, Hashizume Y (1996) Significance of MIB-1, PCNA indices, and p53 protein over-expression in intramedullary tumors of the spinal cord. Noshuyo Byori 13:73–78
Jallo GI, Freed D, Epstein F (2003) Intramedullary spinal cord tumors in children. Childs Nerv Syst 19:641–649
Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh CB, Bjerkvig R, Niclou SP (2011) Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. PNAS 108(9):3749–3754
Lober R, Sharma S, Bell B, Free A, Figueroa R, Sheils CW, Lee M, Cowell J (2010) Pediatric primary intra-medullary spinal cord glioblastoma. Rare Tumor 2:e48
MacDonald TJ, Arenson EB, Ater J et al (2005) Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933. Cancer 104(12):2862–2871
McGirt MJ, Chaichana KL, Atiba A, Attenello F, Woodworth GF, Jallo GI (2008) Neurological outcome after resection of intramedullary spinal cord tumors in children. Childs Nerv Syst 24:93–97
McGirt MJ, Chaichana KL, Atiba A, Attenello F, Yao KC, Jallo GI (2008) Resection of intramedullary spinal cord tumors in children: assessment of long-term motor and sensory deficits. J Neurosurg Pediatr 1:63–67
Merchant TE, Nguyen D, Thompson SJ, Reardon DA, Kun LE, Sanford RA (1999) High-grade pediatric spinal cord tumors. Pediatr Neurosurg 30:1–5
Minehan KJ, Brown PD, Scheithauer BW, Krauss WE, Wright MP (2009) Prognosis and treatment of spinal cord astrocytoma. Int J Radiat Oncol Biol Phys 73:727–733
Nadkarni TD, Rekate HL (1999) Pediatric intramedullary spinal cord tumors. Critical review of the literature. Childs Nerv Syst 15(1):17–28
Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N (2007) Molecular patho-genesis of pediatric astrocytic tumors. Neuro Oncol 9:113–123
Ononiwu C, Mehta V, Bettegowda C, Jallo GI (2012) Pediatric spinal glioblastoma multiforme: current treatment strategies and possible predictors of survival. Childs Nerv Syst 28:715–720
O’Sullivan C, Jenkin RD, Doherty MA, Hoffman HJ, Greenberg ML (1994) Spinal cord tumors in children: long-term results of combined surgical and radiation treatment. J Neurosurg 81:507–512
Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812
Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG, Baker SJ (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28(18):3061–3068
Perkins SM, Rubin JB, Leonard JR, Smyth MD, El Naqa I, Michalski JM, Simpson JR, Limbrick DL, Park TS, Mansur DB (2011) Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys 80:1117–1121
Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL, Sposto R (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346:420–427
Pollack IF, Hamilton RL, James CD, Finkelstein SD, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL (2006) Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. J Neurosurg 105:418–424
Raco A, Piccirilli M, Landi A, Lenzi J, Delfini R, Cantore G (2010) High-grade intramedullary astrocytomas: 30 years' experience at the neurosurgery department of the University of Rome “Sapienza”. J Neurosurg Spine 12:144–153
Reddy AT, Wellons JC 3rd (2003) Pediatric high-grade gliomas. Cancer J 9:107–112
Reimer R, Onofrio BM (1985) Astrocytomas of the spinal cord in children and adolescents. J Neurosurg 63:669–675
Schellinger KA, Propp JM, Villano JL, McCarthy BJ (2008) Descriptive epidemiology of primary spinal cord tumors. J Neuro-Oncol 87:173–179
Sciubba DM, Chaichana KL, Woodworth GF, McGirt MJ, Gokasian ZL, Jallo GI (2008) Factors associated with cervical instability requiring fusion after cervical laminectomy for intradural tumor resection. J Neurosurg Spine 8(5):413–419
Sposto R, Ertel IJ, Jenkin RD, Boescel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Children's Cancer Study Group. J Neurooncol 7:165–177
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
Strik HM, Effenberger O, Schäfer O, Risch U, Wickboldt J, Meyermann R (2000) A case of spinal glioblastoma multiforme: immunohistochemical study and review of the literature. J Neurooncol 50:239–243
Suri V, Das P, Pathak P, Jain A, Sharma MC, Borkar SA, Suri A, Gupta D, Sarkar C (2009) Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol 11(3):274–280
Tendulkar RD, Pai Panadiker AS, Wu S, Kun LE, Broniscer A, Sanford RA, Merchent TE (2010) Irradiation of pediatric high-grade spinal cord tumors. Int J Radiat Oncol Biol Phys 78(5):1451–1456
Tuettenberg J, Grobholz R, Seiz M, Brockmann MA, Lohr F, Wenz F, Vajkoczy P (2009) Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy. J Cancer Res Clin Oncol 135(9):1239–1244
Wolff B, Ann N, Daniels R, Parthey K, Warmuth-Metz M, Kortmann R, Pietsch T, Kramm C, Wolff J (2012) Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database. J Neurooncol 107:139–146
Winograd E, Pencovich N, Yalon M, Soffer D, Beni-Adani L, Constantini S (2012) Malignant transformation in pediatric spinal intramedullary tumors: case-based update. Childs Nerv Syst 28(10):1679–1686
Winters JL, Wilson D, Davis DG (2001) Congenital glioblastoma multiforme: a report of three cases and a review of the literature. J Neurol Sci 188(1–2):13–19
Wood EH, Berne AS, Taveras JM (1954) The value of radiation therapy in the management of intrinsic tumors of the spinal cord. Radiology 63:11–24
Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25(30):4722–4729
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
O’Halloran, P.J., Farrell, M., Caird, J. et al. Paediatric spinal glioblastoma: case report and review of therapeutic strategies. Childs Nerv Syst 29, 367–374 (2013). https://doi.org/10.1007/s00381-013-2023-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-013-2023-x